Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Conditions: Bipolar Disorder; Schizophrenia; Agitation,Psychomotor; Schizo Affective Disorder; Schizophreniform Disorders Intervention: Drug: Sublingual film containing Igalmi Sponsors: BioXcel Therapeutics Inc; Lotus Clinical Research, LLC Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials